Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu and currently employs 5,769 full-time employees. The company went IPO on 2015-12-30. The firm operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The firm mainly operates its businesses in the domestic and overseas markets.
Genscript Biotech Corporation의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Genscript Biotech Corporation 주요 수익원은 Life-science Services and Products이며, 최신 수익 발표에서 수익은 3,516,279,684입니다. 지역별로는 United States이 Genscript Biotech Corporation의 주요 시장이며, 수익은 2,068,502,630입니다.
Genscript Biotech Corporation은 수익성이 있나요?
no, 최신 재무제표에 따르면 Genscript Biotech Corporation의 순손실은 $-532입니다.